Pacira Pharmaceuticals Inc (PCRX) Insider Trading
- $1,702,348.30
- $212,284,233.46
- Sept. 13, 2024
- Andreas Wicki
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 21, 2022 | Insider | 200 | $65.41 | Sell | $13,082.00 | |
Jan. 18, 2022 | SVP | 2,500 | $64.97 | Sell | $162,425.00 | |
Jan. 18, 2022 | Insider | 23,440 | $65.26 | Sell | $1,529,694.40 | |
July 29, 2021 | VP | 90 | $60.81 | Sell | $5,472.90 | |
July 2, 2021 | Insider | 421 | $59.76 | Sell | $25,158.96 | |
June 11, 2021 | VP | 2,003 | $59.85 | Sell | $119,879.55 | |
June 10, 2021 | Insider | 5,689 | $59.60 | Sell | $339,064.40 | |
June 7, 2021 | Insider | 2,278 | $60.50 | Sell | $137,819.00 | |
June 4, 2021 | Insider | 2,276 | $61.04 | Sell | $138,927.04 | |
June 4, 2021 | VP | 1,047 | $61.04 | Sell | $63,908.88 | |
June 4, 2021 | CEO | 14,905 | $61.04 | Sell | $909,801.20 | |
June 4, 2021 | CFO | 2,648 | $61.04 | Sell | $161,633.92 | |
June 2, 2021 | Insider | 2,380 | $62.12 | Sell | $147,845.60 | |
May 11, 2021 | CEO | 21,250 | $60.93 | Sell | $1,294,762.50 | |
April 13, 2021 | Insider | 21,823 | $66.95 | Sell | $1,461,049.85 | |
March 31, 2021 | Insider | 22,224 | $70.61 | Sell | $1,569,236.64 | |
March 17, 2021 | VP | 2,000 | $70.01 | Sell | $140,020.00 | |
March 15, 2021 | VP | 1,520 | $73.28 | Sell | $111,385.60 | |
March 15, 2021 | Director | 10,601 | $73.68 | Sell | $781,081.68 | |
March 11, 2021 | Director | 60,574 | $72.70 | Sell | $4,403,729.80 | |
March 9, 2021 | Director | 35,137 | $70.90 | Sell | $2,491,213.30 | |
Feb. 3, 2021 | CEO | 21,250 | $71.21 | Sell | $1,513,212.50 | |
Jan. 6, 2021 | President | 110 | $60.81 | Sell | $6,689.10 | |
Nov. 16, 2020 | Director | 12,000 | $65.95 | Sell | $791,400.00 | |
Nov. 13, 2020 | Insider | 5,000 | $62.00 | Sell | $310,000.00 | |
Nov. 13, 2020 | President | 25,000 | $63.38 | Sell | $1,584,500.00 | |
Oct. 15, 2020 | CEO | 30,000 | $55.00 | Sell | $1,650,000.00 | |
Sept. 17, 2020 | President | 25,420 | $59.81 | Sell | $1,520,370.20 | |
Sept. 16, 2020 | VP | 3,000 | $60.34 | Sell | $181,020.00 | |
Sept. 16, 2020 | Insider | 27,853 | $60.14 | Sell | $1,675,079.42 | |
Sept. 9, 2020 | Director | 2,216 | $62.02 | Sell | $137,436.32 | |
Aug. 13, 2020 | Director | 34,904 | $61.47 | Sell | $2,145,548.88 | |
Aug. 11, 2020 | VP | 8,180 | $60.50 | Sell | $494,890.00 | |
Aug. 11, 2020 | Director | 106,772 | $61.32 | Sell | $6,547,259.04 | |
Aug. 3, 2020 | SVP | 2,500 | $52.68 | Sell | $131,700.00 | |
July 15, 2020 | CEO | 12,000 | $56.88 | Sell | $682,560.00 | |
June 29, 2020 | VP | 6,000 | $49.47 | Sell | $296,820.00 | |
June 29, 2020 | SVP | 60,101 | $50.27 | Sell | $3,021,277.27 | |
June 8, 2020 | CEO | 17,111 | $48.12 | Sell | $823,381.32 | |
June 4, 2020 | Director | 2,025 | $47.46 | Sell | $96,106.50 | |
June 4, 2020 | VP | 879 | $46.33 | Sell | $40,724.07 | |
June 4, 2020 | Insider | 2,402 | $46.33 | Sell | $111,284.66 | |
June 4, 2020 | CEO | 14,314 | $46.33 | Sell | $663,167.62 | |
June 4, 2020 | SVP | 863 | $46.33 | Sell | $39,982.79 | |
June 4, 2020 | CFO | 1,489 | $46.33 | Sell | $68,985.37 | |
May 21, 2020 | VP | 2,000 | $45.26 | Sell | $90,520.00 | |
May 19, 2020 | VP | 2,000 | $42.81 | Sell | $85,620.00 | |
March 11, 2020 | Insider | 2,500 | $36.50 | Buy | $91,250.00 | |
Feb. 7, 2020 | VP | 170 | $46.81 | Sell | $7,957.70 | |
Jan. 15, 2020 | CEO | 25,000 | $42.68 | Sell | $1,067,000.00 |
Insiders are both buying and selling Pacira Pharmaceuticals Inc stock.
The insider traders at Pacira Pharmaceuticals Inc are: Andreas Wicki, Lauren Bullaro Riker, David M Stack, Kristen Marie Williams, David M. Stack, Paul J Hastings, James S Scibetta, Roy Winston, Max Reinhardt, Gary W Pace, Charles A Reinhart III, John P Phd Longenecker, Daryl Gaugler, Gary Patou, Mark A Kronenfeld, Charles Anthony Laranjeira, Jonathan Slonin, Taunia Markvicka, Luke Evnin, Mark Froimson, Richard Scranton, John Phd Longenecker, James B Jones, John Pratt, Fred A Middleton, Laura Brege, David Stack, Scott Braunstein, Anthony Molloy, James Scibetta, James B. Jones, Marcelo Bigal, Donald C Manning, James S. Scibetta, HASTINGS PAUL J, Dennis Mcloughlin, Kristen Williams, Dennis L Winger, Frank D Lee, and Lauren Riker
The most active insider trader at Pacira Pharmaceuticals Inc is Andreas Wicki with 38 trades.
Andreas Wicki has sold the most Pacira Pharmaceuticals Inc stock with a total value of $103,301,745.13.
Gary W Pace has bought the most Pacira Pharmaceuticals Inc stock with a total value of $714,610.00.
The most recent insider trade for Pacira Pharmaceuticals Inc was on Sept. 13, 2024.
The single biggest insider buy for Pacira Pharmaceuticals Inc was from James S Scibetta with a total value of $306,850.00 on Sept. 11, 2015.
The single biggest insider sell for Pacira Pharmaceuticals Inc was from Andreas Wicki with a total value of $15,187,500.00 on Aug. 11, 2014.